PGAM1, which plays a crucial role in aerobic glycolysis, is a physiologically and pathologically important enzyme and a promising therapeutic target for cancer [[58], [59], [60]], type 2 diabetes [61], and senescence [62,63]. This evidence concerns the gene PGAM1 and type 2 diabetes mellitus.